SARS-CoV-2 Testing

High-Throughput, Low-Cost Detection of SARS-CoV-2 and Dominant SARS-CoV-2 Variants

Scalable Testing for Respiratory Viral RNA Detection

The SARS-CoV-2 pandemic has created an enormous challenge for laboratories and communities worldwide. Currently, laboratories require cost-effective and rapid solutions to track the key SARS-CoV-2 variants currently in circulation, globally. While sequencing-based technologies are commonly used, they are highly complex, expensive, and have a long turnaround time.

To meet these challenges, Agena Bioscience® has developed the MassARRAY® SARS-CoV-2 Variant Panel (RUO), the MassARRAY SARS-CoV-2 Panel (EUA, CE-IVD), and the MassARRAY SARS-CoV-2/Flu Panel (RUO). These panels enable accurate, high-throughput, and low-cost detection of SARS-CoV-2, dominant SARS-CoV-2 variants, and influenza RNA.

  • MAXIMIZE THROUGHPUT – Process up to thousands of samples in a workday with a single MassARRAY System.
  • ENSURE ACCURATE DETECTION – Robust assay design with multiple SARS-CoV-2 targets and pan-assays for influenza A and influenza B.
  • SAVE TIME & MONEY – Low-cost reagents and automated results reporting saves lab resources.
  • SECURE RELIABLE SUPPLY – Immediate availability of instruments and reagents.
Get Started Now

The MassARRAY SARS-CoV-2 Variant Panel is available for Research Use Only.

The MassARRAY SARS-CoV-2 Panel is available for in vitro diagnostic use under Emergency Use Authorization (EUA) from the U.S. FDA and is CE-IVD marked in Europe.

The MassARRAY SARS-CoV-2/Flu Panel is available for Research Use Only.

Don’t see what you need here?

Try our Custom Assay services

Assays by Agena scientists design, develop and functionally verify custom research use assays. Assays can be developed for targeted germline or somatic genotyping, translocations, copy number variants and methylation profiling.

Learn About Custom Assays

We think our customers say it best

Explore customer stories about rapid validation and lab expansion

Customer Success